Who Benefits Most From Early Rhythm Control in Newly Diagnosed Atrial Fibrillation?

Eunice Yang; Hugh Calkins

doi:10.1161/CIRCULATIONAHA.122.060945

Who Benefits Most From Early Rhythm Control in Newly Diagnosed Atrial Fibrillation?

School of Medicine

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	848-850
Number of pages	3
Journal	Circulation
Volume	146
Issue number	11
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.122.060945
State	Published - Sep 13 2022

Keywords

Editorials
ablation techniques
anti-arrhythmia agents
atrial fibrillation
comorbidity
controlled clinical trial
stroke

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Physiology (medical)

Access to Document

10.1161/CIRCULATIONAHA.122.060945

Cite this

@article{e386ded35f41441d8cb41fa4fc4175f4,

title = "Who Benefits Most From Early Rhythm Control in Newly Diagnosed Atrial Fibrillation?",

keywords = "Editorials, ablation techniques, anti-arrhythmia agents, atrial fibrillation, comorbidity, controlled clinical trial, stroke",

author = "Eunice Yang and Hugh Calkins",

year = "2022",

month = sep,

day = "13",

doi = "10.1161/CIRCULATIONAHA.122.060945",

language = "English (US)",

volume = "146",

pages = "848--850",

journal = "Circulation",

issn = "0009-7322",